Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy

ClinicalTrials.gov ID: NCT01229215

Public ClinicalTrials.gov record NCT01229215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 18, 2026, 2:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase Ib/II, Multicenter, Randomized, Single-Masked, Sham Injection-Controlled Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Intravitreal Injections Administered Monthly or Every Other Month to Patients With Geographic Atrophy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase Ib/II, multicenter, randomized, single-masked, sham-injection-controlled study of safety, tolerability, and evidence of activity of FCFD4514S intravitreal injections administered monthly or every other month in patients with geographic atrophy.

Study identification

NCT ID
NCT01229215
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
60 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Mar 31, 2013
Completion
Mar 31, 2013
Last update posted
Nov 1, 2016

2011 – 2013

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Not listed Tucson Arizona 85704
Not listed Beverly Hills California 90211
Not listed San Francisco California 94107
Not listed Santa Barbara California 93103
Not listed Torrance California 90503
Not listed Boynton Beach Florida 33426
Not listed Fort Lauderdale Florida 33334
Not listed Palm Beach Gardens Florida 33410
Not listed Pensacola Florida 32503
Not listed Winter Haven Florida 33880
Not listed Augusta Georgia 30909
Not listed Paducah Kentucky 42001
Not listed Baltimore Maryland 21287
Not listed Boston Massachusetts 02114
Not listed Edina Minnesota 55435
Not listed Lynbrook New York 11563
Not listed New York New York 10003
Not listed Rochester New York 14642
Not listed Charlotte North Carolina 28210
Not listed Beachwood Ohio 44122
Not listed Cincinnati Ohio 45242
Not listed Portland Oregon 97210
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19107
Not listed West Columbia South Carolina 29169
Not listed Nashville Tennessee 37203
Not listed Abilene Texas 79606
Not listed Austin Texas 78705
Not listed Dallas Texas 75231
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01229215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced Sep 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01229215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →